Company / Cost of Revenue
STANDARD BIOTOOLS INC. Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$55.9M
FY2025
5-year range
$55.9M / $60.9M
FY2021-FY2025
Trend
-8.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $61M to $56M over the past 2 years.
Based on SEC 10-K filings.
$56M in FY2025.
Improved from $61M to $56M over the past 2 years.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, cost of revenue decreased 8.2% year-over-year.
- Peak cost of revenue was recorded in FY2024.
- Lowest cost of revenue in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $55.9M | -8.2% |
| FY2024 | $60.9M | +0.0% |
| FY2023 | $60.9M | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $50.0M | +8.6% |
| FY2018 | $46.0M | +7.0% |
| FY2017 | $43.0M | +14233.7% |
| FY2016 | $300.0K | +0.0% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026